3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Breast
1
Conditions
Neoplasms
6
Pancreatic Neoplasms
3
Pancreatic Cyst
2
Wilms Tumor
1
Uveal Melanoma
1
Thyroid Nodule
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neuroendocrine Tumor
1
Hyperthyroidism
1
Hip Fractures
1
Hematologic Neoplasms
1
Goiter
1
Glioma
1
Glioblastoma
1
Frailty
1
Fractures, Spontaneous
1
Financial Stress
1
Interventions
Cyclophosphamide
64
Rituximab
52
fludarabine
36
Prednisone
34
Doxorubicin
29
Vincristine
26
Biopsy
26
Specimen Handling
22
Magnetic Resonance Spectroscopy
20
Bendamustine Hydrochloride
18
pembrolizumab
17
Lenalidomide
16
fludarabine phosphate
15
obinutuzumab
14
Etoposide
14
venetoclax
13
Tacrolimus
12
Mycophenolic Acid
11
Melphalan
10
Dexamethasone
10
zanubrutinib
9
ibrutinib
9
acalabrutinib
9
Whole-Body Irradiation
9
Radiotherapy
9
Gemcitabine
9
Cytarabine
9
Busulfan
9
Mesna
8
Filgrastim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Data Collection
×
1 year
×
Clear all
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled